{{Rsnum
|rsid=10778699
|Chromosome=12
|position=80069304
|Orientation=plus
|GMAF=0.281
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.9 | 41.8 | 47.3
| HCB | 4.4 | 44.4 | 51.1
| JPT | 4.9 | 56.1 | 39.0
| YRI | 3.4 | 33.9 | 62.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 4.4 | 44.4 | 51.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=A
  |Pval=4E-6
  |OR=4.28
  |ORtxt=[2.46-6.1] mg/dL increase
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}